Darrin T. Schellin

Amministratore Delegato presso Goodwin Biotechnology, Inc.

Health Technology

Profilo

Mr. Darrin T.
Schellin is a Chief Executive Officer & Director at Goodwin Biotechnology, Inc. He is on the Board of Directors at Goodwin Biotechnology, Inc. Mr. Schellin was previously employed as a Co-Managing Director by Siegfried Hameln GmbH.

Posizioni attive di Darrin T. Schellin

Società	Posizione	Inizio
Goodwin Biotechnology, Inc. Goodwin Biotechnology, Inc. BiotechnologyHealth Technology Goodwin Biotechnology, Inc. engages in the research, development, validation, and multi-gram manufacture of Antibody Drug Conjugates (ADCs), radio immuno conjugates, and other protein bio conjugates. The firm offers cell line development, cell banking, process development, method development, and project management. The company was founded in 1992 and is headquartered in Plantation, FL.	Amministratore Delegato	15/02/2022

Tutte le posizioni attive di Darrin T. Schellin

Precedenti posizioni note di Darrin T. Schellin

Società	Posizione	Fine
Siegfried Hameln GmbH Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Darrin T. Schellin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Darrin T. Schellin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Siegfried Hameln GmbH Siegfried Hameln GmbH Pharmaceuticals: MajorHealth Technology Siegfried Hameln GmbH engages in the contract development, manufacturing, and packaging of solutions and suspensions in ampoules and vials. Its product portfolio includes injectables, opthalmics, and combination devices. The company was founded by Günther Kerstein in 1950 and is headquartered in Hameln, Germany.	Health Technology
Goodwin Biotechnology, Inc. Goodwin Biotechnology, Inc. BiotechnologyHealth Technology Goodwin Biotechnology, Inc. engages in the research, development, validation, and multi-gram manufacture of Antibody Drug Conjugates (ADCs), radio immuno conjugates, and other protein bio conjugates. The firm offers cell line development, cell banking, process development, method development, and project management. The company was founded in 1992 and is headquartered in Plantation, FL.	Health Technology